3DPBio Lab

Welcome to our state-of-the-art 3D Printing and Bioprinting Lab at the College of Pharmacy. It’s part of our newly developed PharmE3D Research Lab

PHR 5.202



  1. Ultra-smart 3D printing platform for the fabrication of person specific pills (OSP Nbr 202000967 – 001); USD 520,000 (Sep 2020 – Aug 2022); Principal Investigator (PI)
  2. Novel hybrid anti-viral smart drug delivery systems (nParticl3D) to treat COVID-19 (OSP 202001672-001); Jun 2020- Feb 2021; USD 200,000PI
  3. Continuous manufacturing of pharmaceuticals and 3D printable dosage forms; Industrial Strat. & Dev. Fund (OSP Nbr: 201901238 – 001); Sep 19 – Aug 22; USD 654,240PI
  4.  *3D bioprinting of novel bone graft biomaterials for tissue engineering; USD 250,000; PI 
  5. *Smart systems for early stage detection of bowel cancer; USD 897,584; PI